220
Views
17
CrossRef citations to date
0
Altmetric
Review

Adenovirus-vectored drug–vaccine duo as a potential driver for conferring mass protection against infectious diseases

, , &
Pages 1539-1552 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

De-chu Christopher Tang. (2014) A trail blazed through DNA vaccine, noninvasive vaccine, and innate-adaptive immunity duo. Human Vaccines & Immunotherapeutics 10:8, pages 2143-2146.
Read now
De-chu Christopher Tang & Huan Huu Nguyen. (2014) The Yin–Yang arms of vaccines: disease-fighting power versus tissue-destructive inflammation. Expert Review of Vaccines 13:3, pages 417-427.
Read now
Stefania Capone, Anna Morena D’Alise, Virginia Ammendola, Stefano Colloca, Riccardo Cortese, Alfredo Nicosia & Antonella Folgori. (2013) Development of chimpanzee adenoviruses as vaccine vectors: challenges and successes emerging from clinical trials. Expert Review of Vaccines 12:4, pages 379-393.
Read now
De-chu C Tang. (2012) Perspectives on replication-incompetent nasal influenza virus vaccines. Expert Review of Vaccines 11:8, pages 907-909.
Read now
Andrew J Pollard & Lauren Constable. (2011) Expert Review of Vaccines 10-year anniversary issue. Expert Review of Vaccines 10:11, pages 1489-1491.
Read now

Articles from other publishers (12)

Ke Wen, Matthew D. Resch, Ryan Mazboudi, Hannah Mulhall Maasz & Jose M. Galarza. (2023) Novel and efficient method for the reconstruction of adenoviruses through isothermal assembly and its potential applications. Frontiers in Medical Technology 5.
Crossref
Laith AL-Eitan & Malek Alnemri. (2022) Biosafety and biosecurity in the era of biotechnology: The Middle East region. Journal of Biosafety and Biosecurity 4:2, pages 130-145.
Crossref
Wenping Gong, Chao Pan, Peng Cheng, Jie Wang, Guangyu Zhao & Xueqiong Wu. (2022) Peptide-Based Vaccines for Tuberculosis. Frontiers in Immunology 13.
Crossref
Chao Pan, Hua Yue, Li Zhu, Guang-hui Ma & Heng-liang Wang. (2021) Prophylactic vaccine delivery systems against epidemic infectious diseases. Advanced Drug Delivery Reviews 176, pages 113867.
Crossref
De-chu Christopher Tang. (2020) Paradoxical modulation of influenza by intranasal administration of non-replicating adenovirus particles. PLOS ONE 15:11, pages e0241266.
Crossref
Nicolas Çuburu, Selina Khan, Cynthia D. Thompson, Rina Kim, Jort Vellinga, Roland Zahn, Douglas R. Lowy, Gert Scheper & John T. Schiller. (2017) Adenovirus vector‐based prime‐boost vaccination via heterologous routes induces cervicovaginal CD8 + T cell responses against HPV16 oncoproteins . International Journal of Cancer 142:7, pages 1467-1479.
Crossref
Suliman Khan, Muhammad Wajid Ullah, Rabeea Siddique, Ghulam Nabi, Sehrish Manan, Muhammad Yousaf & Hongwei Hou. (2016) Role of Recombinant DNA Technology to Improve Life. International Journal of Genomics 2016, pages 1-14.
Crossref
Yong Yang, Yudan Chi, Xinying Tang, Hildegund C.J. Ertl & Dongming Zhou. (2016) Rapid, Efficient, and Modular Generation of Adenoviral Vectors via Isothermal Assembly. Current Protocols in Molecular Biology 113:1.
Crossref
Ana Fortuna, Gilberto Alves, Ana Serralheiro, Joana Sousa & Amílcar Falcão. (2014) Intranasal delivery of systemic-acting drugs: Small-molecules and biomacromolecules. European Journal of Pharmaceutics and Biopharmaceutics 88:1, pages 8-27.
Crossref
Shipo Wu, Zhe Zhang, Rui Yu, Jun Zhang, Ying Liu, Xiaohong Song, Shaoqiong Yi, Ju Liu, Jianqin Chen, Ying Yin, Junjie Xu, Lihua Hou & Wei Chen. (2014) Intramuscular Delivery of Adenovirus Serotype 5 Vector Expressing Humanized Protective Antigen Induces Rapid Protection against Anthrax That May Bypass Intranasally Originated Preexisting Adenovirus Immunity. Clinical and Vaccine Immunology 21:2, pages 156-164.
Crossref
F. Diaz-San Segundo, G.N. Medina, M.J. Grubman & T. de los Santos. 2014. Encyclopedia of Agriculture and Food Systems. Encyclopedia of Agriculture and Food Systems 327 345 .
Anton V. Borovjagin, Jorge G. Gomez-Gutierrez, Haval Shirwan & Qiana L. Matthews. 2014. Novel Technologies for Vaccine Development. Novel Technologies for Vaccine Development 203 271 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.